文献速递中毒与环境急症消化、代谢与肾脏急症

涉及附子的急性中药中毒临床诊断评分的推导与内部验证

Derivation and internal validation of a clinical diagnostic score for acute Chinese medicine poisoning involving aconite.
PubMed 文献 · Clin Toxicol (Phila) · 2025-06-18
一句话结论在中药中毒人群中,新推导的临床附子中毒评分(0–10分)≥3分时敏感性0.98、阴性预测值0.99,≥4分时特异性0.92、阳性预测值0.84,或有助于实验室确认前早期识别附子中毒。

该研究为回顾性横断面研究,纳入2008年7月1日至2021年6月30日期间报告至香港毒物控制中心的连续实验室确诊中药中毒病例,共542例次,其中附子相关179例次、其他草药363例次,中位年龄55岁(范围4–98岁)。以临床毒理学家诊断加尿液、血清或胃灌洗液检出乌头碱或相关生物碱为参考标准,通过单因素分析及多因素logistic回归识别独立预测因子,并据此构建评分(总分0–10分):低血压3分、草药汤剂或药酒剂型2分、面部或口腔麻木2分、室性心动过速1分、肢体麻木1分、房性或室性期前收缩1分。评分≥3分时敏感性0.98、阴性预测值0.99;≥4分时特异性0.92、阳性预测值0.84;推导期受试者工作特征曲线下面积0.965(95%CI 0.950–0.980),内部验证期0.965(95%偏差校正加速CI 0.947–0.977)。作者认为该评分可能有助于实验室确认前早期识别附子中毒,但需前瞻性外部验证后方可临床采用。

要点

  • 在中药中毒人群中,临床附子中毒评分≥3分时敏感性0.98、阴性预测值0.99,≥4分时特异性0.92、阳性预测值0.84。
  • 评分共0–10分:低血压3分、草药汤剂或药酒剂型2分、面部或口腔麻木2分、室性心动过速1分、肢体麻木1分、房性或室性期前收缩1分。
  • 推导期与内部验证期受试者工作特征曲线下面积均为0.965(推导期95%CI 0.950–0.980;内部验证期95%偏差校正加速CI 0.947–0.977)。
  • 作者认为该评分可能有助于在实验室确认前早期识别附子中毒,但需前瞻性外部验证后方可临床采用。
  • 作者指出该评分在真实世界多样中药中毒人群中的实时判别性能及其对临床管理的影响尚不清楚。

适用人群与场景

  • 研究纳入2008年7月1日至2021年6月30日期间报告至香港毒物控制中心的连续实验室确诊中药中毒患者,共542例次,其中附子相关179例次、其他草药363例次,中位年龄55岁(范围4–98岁)。

诊断标准与关键阈值

  • 参考标准为临床毒理学家诊断急性附子中毒,且患者尿液、血清或胃灌洗液标本中检出乌头碱或相关生物碱。
  • 临床附子中毒评分总分0–10分,分值越高提示附子中毒可能性越大;评分≥3分时敏感性0.98、阴性预测值0.99;评分≥4分时特异性0.92、阳性预测值0.84。

研究设计与关键结果

  • 回顾性横断面研究纳入542例次实验室确诊中药中毒,附子相关179例次、其他草药363例次,中位年龄55岁(范围4–98岁)。
  • 通过单因素分析及多因素logistic回归识别6个独立预测因子并构建评分:低血压(成人收缩压<90 mmHg或儿童低于年龄对应范围)3分、草药汤剂或药酒剂型2分、面部或口腔麻木2分、室性心动过速1分、肢体麻木1分、房性或室性期前收缩1分,总分0–10分。
  • 评分≥3分时敏感性0.98、阴性预测值0.99;评分≥4分时特异性0.92、阳性预测值0.84。
  • 受试者工作特征曲线下面积推导期为0.965(95%CI 0.950–0.980),内部验证(自举法)期为0.965(95%偏差校正加速CI 0.947–0.977)。

证据类型、等级与局限

  • 证据类型:回顾性横断面研究,采用自举法进行内部验证。
  • 局限:该评分在真实世界多样中药中毒人群中的实时判别性能及其对临床管理的影响尚不清楚;作者指出需前瞻性研究在临床采用前外部验证其在真实世界中的实时判别性能。

对床旁实践的改变

  • 在中药中毒背景下,作者认为临床附子中毒评分可能有助于在实验室确认前早期识别附子中毒。
  • 作者指出该评分的实时判别性能在多样中药中毒人群及真实世界环境中尚不清楚,其对临床管理的影响亦未知,需前瞻性外部验证后方可临床采用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Aconitum spp. alkaloids, used in traditional Chinese medicine, are potent cardiotoxins and neurotoxins. Timely diagnosis of aconite poisoning remains challenging due to the long laboratory turnaround time. We aimed to derive and internally validate a diagnostic score for rapid recognition of acute Chinese medicine poisoning involving aconite using clinical parameters.

METHODS: We conducted a retrospective cross-sectional study on consecutive patients with laboratory-confirmed Chinese medicine poisoning reported to the Hong Kong Poison Control Centre between 1 July 2008 and 30 June 2021. The reference standard was the diagnosis of acute aconite poisoning by a clinical toxicologist and laboratory detection of aconitine or related alkaloids in the patients' urine, serum, or gastric lavage specimens. Univariate analyses, followed by multivariable logistic regression, were performed to identify independent predictors of laboratory-confirmed aconite poisoning. A scoring system was developed based on the regression coefficients of the independent predictors and internally validated using bootstrapping.

RESULTS: We identified 542 eligible episodes, of which 179 involved aconite and 363 involved other herbs. The median patient age of the included episodes was 55 years (range 4-98 years). A clinical diagnostic score was developed based on the six independent predictors: hypotension (systolic blood pressure <90 mmHg in adults or < age-appropriate ranges in children, 3 points), herbal decoction or wine formulation (2 points), facial or oral numbness (2 points), ventricular tachycardia (1 point), limb numbness (1 point), and premature atrial or ventricular contractions (1 point). The score ranges from 0 to 10, with a higher score indicating a higher likelihood of aconite poisoning. At the cutoff point of ≥3, the sensitivity and negative predictive value of the score were 0.98 and 0.99, respectively. A higher specificity (0.92) and positive predictive value (0.84) could be achieved with a cutoff point at ≥4. The area under the receiver operating characteristic curve was 0.965 (95% CI: 0.950-0.980) during derivation and 0.965 (95% bias-corrected and accelerated CI: 0.947-0.977) during internal validation.

DISCUSSION: The newly derived Clinical Aconite Poisoning Score is simple to use, but its real-time discriminatory performance in diverse populations with Chinese medicine poisoning in real-world settings and its impacts on clinical management are unknown.

CONCLUSIONS: In the context of Chinese medicine poisoning, the Clinical Aconite Poisoning Score might be useful in early recognition of aconite poisoning before laboratory confirmation. Future prospective studies are warranted to externally validate its real-time discriminatory performance in real-world settings before clinical adoption.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Lam RPK, Chua KK, Ku PY, et al. Derivation and internal validation of a clinical diagnostic score for acute Chinese medicine poisoning involving aconite. Clin Toxicol (Phila). 2025. PMID: 40528738. doi:10.1080/15563650.2025.2512818

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。